Filtered By:
Infectious Disease: SARS
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 1917 results found since Jan 2013.
Kawasaki Disease Associated with SARS-CoV2 in a Pair of Triplets
Pediatric Allergy, Immunology, and Pulmonology, Ahead of Print.
Source: Pediatric, Allergy, Immunology, and Pulmonology - July 19, 2023 Category: Respiratory Medicine Authors: Luisa Berenise Gamez-Gonzalez Luis Xochihua-D íaz Moises Ramirez-Lopez Marcela Colmenero-Rascon Emiy Yokoyama-Rebollar Itzya Hern ández-Santiago Abner Bojalil-Cabildo Marco Antonio Yamazaki-Nakashimada Source Type: research
Politicians, scientists spar over alleged NIH cover-up using COVID-19 origin paper
Two scientists who are coauthors of a 3-year-old article on the origin of the COVID-19 pandemic faced down Republican lawmakers today in what might be the most in-depth discussion ever of a scientific paper in the halls of the U.S. Congress. At a House
subcommittee hearing
, the Republicans asserted that top officials at the U.S. National Institutes of Health (NIH) prompted the researchers to write the paper to try and “kill” the theory that SARS-CoV-2 leaked from a laboratory in Wuhan, China. The scientists, two of its five co-authors, flatly rejected the allegation. And as the hearing extended over 3 hours, com...
Source: Science of Aging Knowledge Environment - July 11, 2023 Category: Geriatrics Source Type: research
The U.S. Scientist At the Heart of COVID-19 Lab Leak Conspiracies Is Still Trying to Save the World From the Next Pandemic
Ralph Baric stepped onto the auditorium stage at the University of North Carolina, Chapel Hill, and looked out at the sparse audience that had come to hear him speak. On the large projector screen hanging behind him, the following words appeared: How Bad the Next Pandemic Could Be, What Might It Look Like, and Will We be Ready. The date was May 29, 2018.
“Well, I have to admit I’m a little worried about giving this talk,” Baric said. “The reason is being labelled a harbinger of doom.” The screen shifted, and images of the four horsemen of the apocalypse—Death, Famine, War, and Plague&mda...
Source: TIME: Health - July 11, 2023 Category: Consumer Health News Authors: Dan Werb Tags: Uncategorized COVID-19 feature freelance Source Type: news
Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana
Conclusion
The results of our study indicate a high incidence of non-serious AEFI and the rare occurrence of serious AEFI after COVISHIELD vaccination in healthcare workers. The rate of AEFI was higher after the first dose than after the second dose. Sex, age, previous SARS-CoV-2 infection, allergies and comorbidity were not significantly associated with the onset and duration of AEFI.
Source: BMJ Open - June 28, 2023 Category: General Medicine Authors: Marfoh, K., Samba, A., Okyere, E., Acheampong, F., Owusu, E., Darko, D. N. A., Zakariah, J., Mensa, H., Aidoo, E., Mohammed, Y. Tags: Open access, Immunology (including allergy), COVID-19 Source Type: research
COVID-19, Coronavirus Vaccines, and Possible Association with Lipsch ütz Vulvar Ulcer: A Systematic Review
In conclusion, COVID-19 and immunization against SARS-CoV-2 add to Epstein-Barr virus as plausible triggers of Lipschütz genital ulcer.
Source: Clinical Reviews in Allergy and Immunology - June 26, 2023 Category: Allergy & Immunology Source Type: research
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
Vaccine. 2023 Jun 15:S0264-410X(23)00714-4. doi: 10.1016/j.vaccine.2023.06.039. Online ahead of print.ABSTRACTBasophil activation test (BAT) can tackle multiple mechanisms underlying acute and delayed hypersensitivity to drugs and vaccines and might complement conventional allergy diagnostics but its role in anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-related hypersensitivity is ill-defined. Therefore, 89 patients with possible hypersensitivity (56 % with delayed mucocutaneous manifestations) to anti-SARS-CoV-2 vaccines were tested with BAT for Macrogol 3350, DMG-PEG 2000, PEG 20000, polysorba...
Source: Vaccine - June 22, 2023 Category: Allergy & Immunology Authors: Patrizia Pignatti Giuseppe Alvise Ramirez Marco Russo Paolo Marraccini Serena Nannipieri Chiara Asperti Fabrizio Della Torre Antonio Tiri Beatrice Maria Gatti Antonella Gurrado Antonio Meriggi Giovanni Benanti Maria Bernadette Cilona Paolo Pigatto Samuele Source Type: research
Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: Evidence for immunogenicity of PEG
Conclusions: The small percentage of people who have extremelevels of anti-PEG Ab in their blood may be at increased risk for HSRs/anaphylaxis to PEGylated vaccines and other PEGylated injectables. This risk might be further increased by the anti-PEG immunogenicity of these vaccines. Screening for anti-PEG Ab "supercarriers" may help predicting reactors and thus preventing these adverse phenomena.PMID:37330369 | DOI:10.1016/j.vaccine.2023.06.009
Source: Vaccine - June 17, 2023 Category: Allergy & Immunology Authors: Gergely Tibor Kozma Tam ás Mészáros Petra Ber ényi R éka Facskó Zs ófia Patkó Csaba Zs Ol áh Adrienne Nagy Tam ás Gyula Fülöp Kathryn Anne Glatter Tam ás Radovits B éla Merkely J ános Szebeni Source Type: research
Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children
Ann Allergy Asthma Immunol. 2023 Jun 13:S1081-1206(23)00417-9. doi: 10.1016/j.anai.2023.06.009. Online ahead of print.NO ABSTRACTPMID:37321447 | DOI:10.1016/j.anai.2023.06.009
Source: Annals of Allergy, Asthma and Immunology - June 15, 2023 Category: Allergy & Immunology Authors: Iris Kim Tricia Morphew Christine Chou Louis Ehwerhemuepha Stanley Galant Source Type: research
Controller therapy attenuates asthma exacerbations associated with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children
Nearly 80% of asthma exacerbations are associated with viral respiratory infections.1 The first cases of coronavirus disease 2019 (COVID-19) because of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in late December 2019 in Wuhan, People's Republic of China, and was first reported in the United States in January 2020.2
Source: Annals of Allergy, Asthma and Immunology - June 12, 2023 Category: Allergy & Immunology Authors: Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant Tags: Letters Source Type: research
Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children
Abbreviations: Coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), inhaled corticosteroids (ICS), oral corticosteroid (OCS), short-acting beta-agonist (SABA), long-acting beta-agonist (LABA), leukotriene receptor antagonist (LTRA), rate ratios (RR), polymerase chain reaction (PCR)
Source: Annals of Allergy, Asthma and Immunology - June 12, 2023 Category: Allergy & Immunology Authors: Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant Tags: Letters Source Type: research
Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks et al
We read with great interest the Global Rheumatology Alliance report on COVID-19 on biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA).1 The first important result of the registry database is that B-cell depletion, by compromising the primary antibody response, increases the severity of infected patients. Considering the critical role of B cells in the adaptive immune response, this sounds quite correct.2 Even the data on interleukin 6 and tumour necrosis factor (TNF) inhibitors appear quite understandable considering the systemic inflammation raised by SARS-CoV-2 infe...
Source: Annals of the Rheumatic Diseases - June 12, 2023 Category: Rheumatology Authors: Gremese, E., Ferraccioli, G. Tags: ARD, COVID-19 Correspondence Source Type: research
The controversial effect of smoking and nicotine in SARS-CoV-2 infection
The effects of nicotine and cigarette smoke in many diseases, notably COVID-19 infection, are being debated more frequently. The current basic data for COVID-19 is increasing and indicating the higher risk of ...
Source: Allergy, Asthma and Clinical Immunology - June 1, 2023 Category: Allergy & Immunology Authors: Zahra Salehi, Bibi Fatemeh Nobakht Motlagh Ghoochani, Yazdan Hasani Nourian, Sadegh Azimzadeh Jamalkandi and Mostafa Ghanei Tags: Review Source Type: research
Study provides deeper insight into long COVID
This study is an important step toward defining long COVID beyond any one individual symptom, " said study author Dr. Leora Horwitz, director of the Center for Healthcare Innovation and Delivery Science and co-principal investigator for the RECOVER Clinical Science Core at NYU Langone Health. " This research definition — which may evolve over time — will serve as a foundation for scientific discovery and treatment design. "The researchers say studying the underlying biological mechanisms of long COVID is central to advancing informed interventions and identifying effective treatment strategies.
In addition to establish...
Source: The University of Arizona: Health - May 30, 2023 Category: Universities & Medical Training Authors: mittank Source Type: research
